Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02355691 · ClinicalTrials.gov registry record · NA

Improvement in Wound Healing With Negative Pressure Wound Therapy for Postoperative Total Hip Arthroplasty

A NA study, sponsored by University of North Carolina, Chapel Hill.

Terminated
Registry status
NA
Development phase
16
Enrollment target

NCT02355691 is a NA study that was terminated before completion, run by University of North Carolina, Chapel Hill. The registered enrollment target is 16 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02355691, a NA study, was terminated before completion, sponsored by University of North Carolina, Chapel Hill.

TERMINATED
Registry status
NA
Development phase
16 participants
Enrollment target

Study Summary

For the target population of adult patients following primary total hip arthroplasty, the randomized clinical trial will be used to evaluate the efficacy of the use of a mobile negative pressure wound therapy(NPWT) device compared to a standard absorptive dressing in the immediate postoperative period. We will apply two dressing types and evaluate the postoperative wounds with a wound scoring system (ASEPSIS) that incorporates multiple variables of wound infection risk.

Interventions

  • DEVICE PREVENA

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2015-05
Est. Completion 2017-05
Phase NA

What the Registry Record Tells You About NCT02355691

The ClinicalTrials.gov registry entry for NCT02355691 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which PREVENA is the first listed.

NCT02355691 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02355691 about?

NCT02355691 is a clinical study titled "Improvement in Wound Healing With Negative Pressure Wound Therapy for Postoperative Total Hip Arthroplasty". For the target population of adult patients following primary total hip arthroplasty, the randomized clinical trial will be used to evaluate the efficacy of the use of a mobile negative pressure wound therapy(NPWT) device compared to a standard absorptive dressing in the immediate postoperative peri...

What is the current status of trial NCT02355691?

This trial is currently terminated. It is a NA study. The enrollment target is 16 participants. The study started on 2015-05. Estimated completion is 2017-05.

What interventions are being tested in trial NCT02355691?

The interventions under investigation include: PREVENA (DEVICE).

Who is sponsoring clinical trial NCT02355691?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.